Anant Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.80 M
as on 16-11-2024
- Paid Up Capital ₹ 1.69 M
as on 16-11-2024
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.49 Cr
as on 16-11-2024
- Revenue -8.19%
(FY 2023)
- Profit -250.23%
(FY 2023)
- Ebitda -77.43%
(FY 2023)
- Net Worth -20.82%
(FY 2023)
- Total Assets 5.81%
(FY 2023)
About Anant Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.80 M and a paid-up capital of Rs 1.69 M.
The company currently has active open charges totaling ₹5.49 Cr.
Anil Godbole, Anupama Godbole, and Ajit Godbole serve as directors at the Company.
- CIN/LLPIN
U24100MH2005PTC151401
- Company No.
151401
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationAmbernath East, Maharashtra
- Telephone
- Email Address
- Website
- Social Media
What products or services does Anant Pharmaceuticals Private Limited offer?
Anant Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Mineral Supplement, Speciality Chemicals, API Intermediate, API Impurities, Dorzolamide Intermediate, Pharma Ingredients & Raw Materials, Pyridine Derivatives.
Who are the key members and board of directors at Anant Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Godbole  | Managing Director | 10-Feb-2010 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Godbole | Director | 18-Feb-2005 | Current |
| Anupama Godbole | Director | 18-Feb-2005 | Current |
Financial Performance of Anant Pharmaceuticals.
Anant Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.19% decrease. The company also saw a substantial fall in profitability, with a 250.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anant Pharmaceuticals?
In 2023, Anant Pharmaceuticals had a promoter holding of 67.11% and a public holding of 32.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 16 Aug 2024 | ₹5.90 M | Open |
Others Creation Date: 01 Jan 2024 | ₹2.50 M | Open |
Others Creation Date: 14 Mar 2023 | ₹2.50 M | Open |
How Many Employees Work at Anant Pharmaceuticals?
Anant Pharmaceuticals has a workforce of 40 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anant Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anant Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
